1. Treatment of Metastatic malignant melanoma with 24 hours continuous venous infusion of dacarbazine and cisplatin . J Surg Oncol. 48 (3):199-201, 1991
  2. Cigarette smoking among young physicians and their approach to the smoking problem of their patients. J Cancer Educ. 7(3):237-40,1992
  3. Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer. J Surg Oncol. 50 (4):251-3, 1992
  4. Primary gastrointestinal lymphomas in Turkey: a retrospective analysis of clinical features and results of treatment. J Surg Oncol. 51 (4):270-3, 1992
  5. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer. 72(2):587-93,1993
  6. A phase I dose escalation study of high dose thiotepa,melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplant.25(7):697
  7. Neoadjuvant chemoterapy in locally advanced breast cancer:a preliminary report.Turkish Oncology Study Group.Tumori. 85(6):483-7,1999
  8. Clinicopathologic characteristics of colorectal cancer in patients under 50 years of age: experience of an oncology center. Tumori, 87(2), 74-7, 2001
  9. Effect of cisplatin on skin metastasis in breast cancer patients. Onkologie, 24, 576-579 (2001).
  10. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor(rhG-CSF): a randomized evaluation of different doses of rhG-CSF.Br J Haematol. 116(2):468-74,2002
  11. A Randomized trial of assessment of efficacy of leukapheresis volumes,8liters vs 12 liters. Bone Marrow Transplant. 29(11):893-7,2002
  12. Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation.Br J Haematol. 118(4): 1104-11,2002
  13. Prognostic implication of nm23-H1 expression in colorectal carcinomas. Pathology.34(5):427-32,2002
  14. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract. 198 (10):665-74,2002
  15. Tamoxifen therapy and hepatic steatosis. Neoplasma, 49, 61-64,2002
  16. Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. Pathol Res Pract, 198, 7-12 ,2002
  17. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer, 95, 663-667,2002
  18. Primary high grade malignant lymphoma of bladder. Urol Oncol, 7, 181-183,2002
  19. Primary mediastinal yolk sac tumor in a 66-year-old woman. Med Princ Pract, 11, 218-220,2002
  20. A case of Sweet’s syndrome developed after the treatment of herpes simplex infection in a metastatic breast cancer patient. J Cutan Pathol, 29, 301-304, 2002
  21. Evaluation of serum cyctatin C levels and 99mTecnetiummercaptoacetyltriglcine-3 renal scintigraphy for the early detection of cisplatin-induced renal toxicity in cancer patients. Nephrology, 7, 56-60,2002
  22. Significance of serum vascular endothelial growth factor, insuline-like growth factor-I levels and nitric oxide activity in breast cancer patients. Breast, 12, 104-110, 2003
  23. Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages. Journal of Trace Elements in Experimental Medicine, 16, 87-94,2003
  24. Serum leptin levels are associated with tamoxifen-induced hepatic steatosis. Curr Med Res Opin, 19, 47-50,2003
  25. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma, 50, 41-46 ,2003
  26. Effect of different chemotherapy regimens on locally advanced breast cancer. Neoplasma, 50, 210-216,2003
  27. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stages. Am J Clin Oncol, 26, 416-21, 2003
  28. Gingival metastasis of malignant mesenchymal tumour in the tigh. Brit J Oral Max Sur, 41, 59-61,2003
  29. Serum interleukin-18 and nitric oxide activity in bladder carcinoma. Eur Cytokine Netw, 14, 163-67, 2003
  30. Long term survival in a patient with malignant pleural mesothelioma after gemcitabine treatment. Case Reports and Clinical Practice Review, 4,23,2003
  31. High-dose thiotepa,melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplant. 31(9): 755-61,2003
  32. Serum levels of interleukin-18 and nitrite+ nitrate in renal cell carcinoma patients with different tumor stage and grade. Neoplasma, 51, 26-29,2004
  33. Polymyositis and Hepatitis Concurrent with Breast Cancer,Med Princ Pract. 13(3): 171-175,2004
  34. Pulmonary resection in a metastatic breast cancer patient with fourteen years survival: A case report. Case Reports and Clinical Practice Review, 5, 12-13,2004
  35. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions. Neoplasma, 51, 209-213,2004
  36. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery. Intern Med J. Jun;34(6):310-5,2004
  37. Gemcitabine induced pulmonary injury. Case Reports and Clinical Practice Review, 5, 178-179,2004
  38. Effect of tamoxifen on serum IL- 18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. Clin Exp Immuno ;137(3):546-51,2004
  39. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma. Tumor ;91(1):46- 52,2005
  40. Inhibitory effect of 5-Fluorouracil on cytochrome P450 2C9 activity in cancer patients. Basic Clin Pharmacol Toxicol ;98(2):197-200,2006
  41. Serum neopterin levels in patients with breast cancer. Med Oncol; 25(4):403-407,2008
  42. Serum big endotelin-1 levels in female patients with breast cancer.Int immunopharmacol;8(8):1119-1123,2008
  43. Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment. Onkologie;31(6):309-313,2008
  44. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients. J BUON;17(4): 663-8, 2012
  45. Long-term follow-up of a hip joint osteoblastoma after intralesional curettage and cement packing: a case report. Acta Orthop Traumatol Turc; 47(3):218-22, 2013